Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei V Krivtsov

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Protocols in Pharmacology|September 12, 2017
Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML)Matthew C Stubbs, Andrei V Krivtsov
Nature Reviews. Cancer|October 25, 2007
MLL translocations, histone modifications and leukaemia stem-cell developmentAndrei V Krivtsov, Scott A Armstrong
Science (New York, N.Y.)|November 28, 2012
Cancer. Can one cell influence cancer heterogeneity?Andrei V Krivtsov, Scott A Armstrong
Annals of the New York Academy of Sciences|October 3, 2009
Transformation from committed progenitor to leukemia stem cellsAndrei V Krivtsov, Zhaohui Feng, Scott A Armstrong
Cold Spring Harbor Perspectives in Medicine|March 1, 2017
Mixed-Lineage Leukemia Fusions and Chromatin in LeukemiaAndrei V Krivtsov, Takayuki Hoshii, Scott A Armstrong
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Gene expression profiling of leukemia stem cellsAndrei V Krivtsov, Yingzi Wang, Zhaohui Feng, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 28, 2022
Macrophage polarization in hypoxia and ischemia/reperfusion: Insights into the role of energetic metabolismElmira I Yakupova, Grigoriy V Maleev, Andrei V Krivtsov, et al.
Science (New York, N.Y.)|March 27, 2010
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AMLYingzi Wang, Andrei V Krivtsov, Amit U Sinha, et al.
Journal of Cellular Biochemistry|January 18, 2007
Jedi--a novel transmembrane protein expressed in early hematopoietic cellsAndrei V Krivtsov, Fedor N Rozov, Marina V Zinovyeva, et al.
Blood|December 6, 2008
HOXA9 is required for survival in human MLL-rearranged acute leukemiasJoerg Faber, Andrei V Krivtsov, Matthew C Stubbs, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Protocols in Pharmacology|September 12, 2017
Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML)Matthew C Stubbs, Andrei V Krivtsov
Nature Reviews. Cancer|October 25, 2007
MLL translocations, histone modifications and leukaemia stem-cell developmentAndrei V Krivtsov, Scott A Armstrong
Science (New York, N.Y.)|November 28, 2012
Cancer. Can one cell influence cancer heterogeneity?Andrei V Krivtsov, Scott A Armstrong
Annals of the New York Academy of Sciences|October 3, 2009
Transformation from committed progenitor to leukemia stem cellsAndrei V Krivtsov, Zhaohui Feng, Scott A Armstrong
Cold Spring Harbor Perspectives in Medicine|March 1, 2017
Mixed-Lineage Leukemia Fusions and Chromatin in LeukemiaAndrei V Krivtsov, Takayuki Hoshii, Scott A Armstrong
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Gene expression profiling of leukemia stem cellsAndrei V Krivtsov, Yingzi Wang, Zhaohui Feng, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 28, 2022
Macrophage polarization in hypoxia and ischemia/reperfusion: Insights into the role of energetic metabolismElmira I Yakupova, Grigoriy V Maleev, Andrei V Krivtsov, et al.
Science (New York, N.Y.)|March 27, 2010
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AMLYingzi Wang, Andrei V Krivtsov, Amit U Sinha, et al.
Journal of Cellular Biochemistry|January 18, 2007
Jedi--a novel transmembrane protein expressed in early hematopoietic cellsAndrei V Krivtsov, Fedor N Rozov, Marina V Zinovyeva, et al.
Blood|December 6, 2008
HOXA9 is required for survival in human MLL-rearranged acute leukemiasJoerg Faber, Andrei V Krivtsov, Matthew C Stubbs, et al.
Pageof 4